Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Monthly Archives: January 2014

Monmouth University School of Science to Host 12-Week Summer Research Program

West Long Branch, NJ, January 29, 2014 ― Monmouth University School of Science will present 2014 Summer Research Program (SRP) from May 22 through August 18, 2014.

Participants will experience a life-changing summer by working with faculty members on exciting research projects.  Join other motivated students for the School of Science Summer Research Program.  This 12-week program is a challenging opportunity to work on collaborative research projects under the supervision of School of Science faculty and staff. Continue reading

NJ Entrepreneurial Network to Host NJ Secretary of Higher Education Rochelle Hendricks on February 12

Princeton, NJ, January 23, 2014 ― The New Jersey Entrepreneurial Network (NJEN) will host New Jersey Secretary of Higher Education Rochelle Hendricks at an event that will be held Wednesday, February 12, from 5:30 to 7:30 p.m. at Princeton University’s Friend Center Convocation Room at Olden and William Streets in Princeton, NJ.

Every year, NJEN provides the entrepreneurial community with an evening of posters, networking and information at Princeton University.  Those providing posters can introduce their businesses to important contacts among academics, small and large businesses, potential funding sources and professional services providers. Continue reading

Opinion: Innovation in Medicine Isn’t Optional – It’s Imperative

Washington, DC, January 22, 2014Former Food and Drug Administration Commissioner Andrew von Eschenbach and Paul Howard write in The Hill the following regarding innovation, research and biopharmaceuticals:

*     *     *

It’s hard to open a magazine or newspaper these days without reading an article bemoaning the high price of new medicines, particularly for cancer.  While high prices (and high copays) produce enormous challenges for some patients, it would be wrong to assume that pricing itself is the problem – it’s simply the result of an extraordinarily inefficient and expensive process for bringing new medicines to market.

Using the government’s enormous purchasing power to clamp down on drug prices, as called for by some advocate, would merely reduce incentives for innovation. Reforming the drug development and approval system, however, would accelerate patient access to better treatments and sharply lower the cost of developing new technologies – from stem cells to immune therapies ‒ that can radically alter the lifetime cost of treatment for desperately ill patients – and pave the way for even more effective generics after patent protection eventually expires. Continue reading

Battelle Report: Biopharma Sector Stepping Up to Improve STEM Education in U.S.

Washington, DC, January 22, 2014 ― Innovative biopharmaceutical companies and their corporate foundations are making significant contributions to U.S. science, technology, engineering and math (STEM) education through a broad range of local, state and national level programs and initiatives aimed at elementary through post-secondary education, according to a first-of-its-kind report by the Battelle Technology Partnership Practice.

The efforts, which represent important financial and in-kind investments, are characterized in the new report, supported by the Pharmaceutical Research and Manufacturers of America and unveiled today at a STEM Saves Lives event in Washington, DC, hosted by U.S. News & World Report and PhRMA. Continue reading

Rutgers Camden’s Jan. 30 Conference to Focus on Delaware Valley’s Economy

Cherry Hill, NJ, January 17, 2014 ― Current and future economic conditions for the Delaware Valley will be examined during the first 2014 session of the Rutgers Camden Business Outlook, reports The Daily Journal.

The conference will be held from 7:30 to 9:30 a.m. on Thursday, January 30. Real estate, health care, energy and their roles in the current regional economy will be discussed during the event. Continue reading

Governor Chris Christie’s 2014 State of the State Address

Trenton, NJ, January 14, 2014 — The following is the text (as prepared for delivery) of Governor Christ Christie’s State of the State Address, which he delivered yesterday to the new, the 216th Legislature.

*     *     *

 Lt. Governor, Mr. Speaker, Mr. President, Legislators, friends, fellow New Jerseyans:

The last week has certainly tested this Administration.  Mistakes were clearly made. And as a result, we let down the people we are entrusted to serve.  I know our citizens deserve better. Much better.

I am the governor and I am ultimately responsible for all that happens on my watch – both good and bad. Continue reading

A Super Community Blood Drive Event Set for January 14

Trenton, NJ, January 8, 2014 ― A Super Community Blood Drive will be held on Tuesday, January 14, 2014.  The daylong event, which will be sponsored by Novartis Pharmaceuticals Corporation, will be held at the Sun National Bank Center at 81 Hamilton Avenue in Trenton. 

With free entertainment by Joey Vincent, Funny Man with a Horn, Paper Mill Playhouse Broadway Show Choir and live music with Rich Genoval.  In addition, the event will feature former NY Jets WR Wayne Chrebet and Salutes to the Troops. 

For information on how to donate, click here.  For the event flyer, click here.